glp-1 retatrutide for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Unapproved weight loss drug retatrutide

Assess (Summ) 64 , 13 (2003)

doi: 10.2337/dc07-0141 Summary Keywords bariatric surgery, type 2 diabetes mellitus, recurrent weight gain, glucagon-like peptide-1, conversional surgery Citation Xiao H, Du Y, Tan Y and Ren Y (2024) Prognosticating post-bariatric surgery outcomes and management of postoperative recurrent weight gain and diabetes recurrence

Osteomalacia, a condition involving the softening of bones due to impaired mineralization, was rare but occurred about twice as often in the GLP-1 group

A representative full cycle: On (812 weeks): 4 weeks daily 4 weeks at 5/week remaining weeks at 23/week maintenance